The relationship between chronic prostatitis and fertility has been disputed for many years. Several groups have shown infection and autoimmune response against prostate antigens could have a deleterious effect on semen quality and fertility. This study was conducted to test the hypothesis that Omi/HtrA2-induced apoptosis in chronic prostatitis could be a mechanism underlying the observed clinical benefit. The Omi/HtrA2 serine protease is a nuclear-encoded mitochondrial protein, which can be released from mitochondria into the cytosol after apoptosis stimuli, inducing apoptosis in caspase-dependent and independent manners. Forty-one patients diagnosed as suffering from chronic prostatitis were included. Healthy normal individuals were included as controls. Human spermatozoa in the semen were purified by Percoll-gradient technique to separate the seminal plasma and other round cells. Measurements for sperm concentration, motility, morphology, proinflammatory cytokines, Omi/HtrA2 mRNA and protein levels in spermatozoa of chronic protatitis patients, were performed accordingly. Significantly increased levels of proinflammatory cytokines were detected in seminal plasma from these prostatitis patients. Omi/ HtrA2 mRNA and protein levels were significantly higher in prostatitis men than in normal men. This study shows that chronic prostatitis patients present important alterations in their semen quality parameters, Omi/HtrA2 mRNA and protein levels of spermatozoa. We speculate that the inflammatory process involved may affect male fertility by release of proapoptotic protein Omi/HtrA2.
Introduction
Chronic prostatitis is a common diagnosis but very little is understood about the aetiology and the pathogenesis of the disease. 1, 2 Men with chronic prostatitis present an episodic and relapsing condition characterized by pelvic pain, irritative voiding symptoms and effects on sexual function. 3 The symptoms of the disease are suggestive of an infection in the prostate gland and bacterial infections occur in 5-10% of patients. However, a large body of evidence accumulated over many years has failed to provide convincing proof that some fastidious organisms are responsible for symptoms in a significant proportion of men who present symptoms of chronic prostatitis. Recently, several groups reported that autoimmune response against prostate antigens and the inflammatory process involved may play an important role in the pathogenesis of chronic prostatitis. [4] [5] [6] Chronic prostatitis associated, mainly of infectious origin, autoimmunity and inflammatory process, with abnormalities in semen quality and function, 7 then male fertility would be impaired by prostate secretion meeting sperm cells during ejaculation, or including a direct effect of inflammation on the testis and epididymis, however, the molecular mechanism of it is not fully understood. Omi/HtrA2 is a nuclear-encoded mitochondrial serine protease, which can released from mitochondria into the cytosol after apoptosis stimuli, such as tumour necrosis factor (TNF), growth-factor depletion, inflammation factors, DNA damaging agents, irradiation and so on, inducing apoptosis in caspase-dependent and independent manners. 8 In this study, we analysed a group of patients with chronic prostatitis in order to investigate whether reduced semen quality, mainly of inflammatory factors, induced release of Omi/HtrA2 would have any effect on male fertility.
Materials and methods

Patients
We included 41 patients (mean7s.d. age: 38.6277.65 years, range 18-49) and 15 control volunteers (age: 30.4574.83 years, range 24-45) from Department of Urology, Shanghai Jiaotong University Affiliated Sixth People's Hospital in our study. Normal individuals answered a questionnaire and had no history of any genitourinary symptoms, instrumentation or surgery. They underwent the same assessment as patients. Patients and controls agreed to donate blood samples and semen; they had not been taking antibiotics, nonsteroidal anti-inflammatory drugs or steroids for 4 weeks before, or during the study. Volunteers who had undergone vasectomy were specifically excluded. A diagnosis of chronic symptomatic prostatitis was given in cases of a history of X3 months of pelvic or genital pain, or both, associated with voiding and/or sexual dysfunction and painful digital rectal examination of the prostate. All patients underwent a standard evaluation, including digital rectal examination, microscopic examination and culture of urine and semen. To discriminate between patients with infectious and non-infectious chronic prostatitis, conventional and non-conventional bacterial cultures were performed in their urine and semen. We could detect infection of known prostatic pathogens (e.g.: Escherichia coli; Staphylococcus aureus; Klebsiella sp; Chlamydia trachomatis; Candida albicans; Trichomonas sp) in infectious chronic prostatitis patients in 41 patients, and we therefore named this group as group A (patients with type II NIH prostatitis). Group B age-matched volunteers with no history of genitourinary disease, who were used as control group, did not show any presence of an infectious agent either in semen or in urine (group B, n ¼ 12).
Semen analysis
Semen samples were collected directly into a sterile container by masturbation after 2-7 days of sexual abstinence. Semen samples and blood were obtained at the same visit. Standard clinical semen analysis was performed according to World Health Organization (1999) criteria. Semen analysis consisted of determination of sample volume, sperm density (concentration), progressive motility, vitality (eosin exclusion), morphology (World Health Organization (1992)) classification and Kruger classification, pH, and concentrations of citrate and fructose. Citrate and fructose were measured as tests of function of the prostate and seminal vesicles, respectively. Identification of leucocytes and other cells was carried out by a peroxidase cytochemical technique. Results were expressed as 1 Â 10 6 leucocytes/ml. To assess the functional integrity of sperm membrane, hypo-osmotic swelling (HOS) test was used as described previously (World Health Organization, 1999).
Cytokines in seminal plasma
TNF-a and interleukin (IL)-1b were assayed in seminal plasma by the use of a commercially available chemiluminescence immunometric assay kit (Immulite; DPC, Los Angeles, CA, USA). The assay was performed according to the manufacturer's instructions in an automatic analyser (Immulite). The cytokine contents were expressed in pg/ml, according to standard curves ranging from 1.7 to 1000 pg/ml for TNF-a, and from 1.5 to up to 1000 pg/ml for IL-1b.
Sperm samples
Sperm samples were obtained from A and B groups men. Semen was collected by masturbation after 3 days of sexual abstinence and allowed to liquefy for 30-60 min at room temperature. A semen analysis was performed according to WHO (World Health Organization, 1999) guidelines. Eosin-nigrosin staining was used for assessing viability of selected sperm and the samples with more than 5% of dead spermatozoa were excluded from this study. Diff-Quik staining was used to evaluate the sperm morphology. Normozoospermic (sperm concentration X20 Â 10 6 /ml, total of motility grades A and B X50%, normal sperm morphology X30%, n ¼ 12) and prostatitis semen (sperm concentration X20 Â 10 6 /ml, total of motility grades A and B p30%, normal sperm morphology X30%, n ¼ 41) were selected for the study. Spermatozoa were purified by the Percoll-gradient technique (four layers: 47.5, 57, 76 and 95%) to separate seminal plasma and also remove other round cells. After centrifugation (20 min at 400 g, 251C), the spermatozoa were collected from the interface 57-76% and the under layer of 95%, and then washed twice with phosphatebuffered saline buffer. The washed spermatozoa were stored at À801C for RNA analysis. In order to detect the purification of selected sperm, the samples were examined under microscope. No remaining round cells were observed. This study was approved by the ethical committee of the hospital and all participants signed the consent form permitting to use their sperm samples in the study.
RT-PCR assay
Total RNA from purified spermatozoa was extracted with TRIzol Reagent (Invitrogen, Carlsbad, CA, USA). Two micrograms of total RNA was reversed transcribed with Reverse Transcription System (Promega, Madison, WI, USA). Polymerase chain reaction (PCR) was performed on reverse transcription (RT) products 5 ml, 2.5 IU of Taq DNA polymerase, 10 Â PCR buffer 5 ml, 25 mM MgCl 2 4 ml, 10 mM dNTP 1 ml and 50 pmol of the forward and reverse primers in a final volume of 50 ml. Primer for Omi/HtrA2 (sense-5 0 -TCCTTTGCCATCCCTTCT-3 0 , antisense-5 0 -TCTGTCTCGGTGCCCTCA-3 0 ) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH, sense-5 0 -TGGGTGTCGCTGTTGAAGTC-3 0 , antisense-5 0 -GCTGG CGCTGAGTACGTCGT-3 0 ) was synthesized by Shanghai Shenggong Company (Shanghai, China). The PCR conditions were as follows: initial denaturation at 941C for 5 min, then 30 cycles of 951C for 30 s, 551C for 45 s, 721C for 90 s and 721C for 10 min. The PCR products were analysed using a Rapid Agarose Gel Electrophoresis System (Wealtec CORP, Sparks, NV, USA) in 2.0% agarose gels in 0.5 Â TBE (Tris.base, Boric acid, EDTA) buffer (1 h at 70 V). The PCR products for Omi/HtrA2 and GAPDH were 450 and 604 bp. The intensities of the bands were quantitated by Dolphin software (Wealtec CORP, USA). The relative values were calculated by dividing the densitometric signals for Omi/HtrA2 by the signal obtained with the internal standard GAPDH.
Western blot analysis
For Western blotting, Percoll purified spermatozoa were homogenized in radioimmunoprecipitation assay buffer
NaCl, 1% NP-40, 0.5% sodium dodecyl sulphate (SDS), 1 mg/ml Aprotinin, 1 mmol/l phenyl methyl sulphonyl fluoride). The homogenate was clarified by centrifugation at 15 000 g for 15 min and the concentration of protein in homogenates was determined by the Bio-Rad protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Aliquots (30 mg) of homogenate protein were separated by discontinuous 8% SDS-polyacrylamide gel electrophoresis. The separated proteins were electroblotted onto polyvinylidene fluoride membrane using a tank-blotting system at 200 mA for 2 h. After blocking the nonspecific binding sites with non-fat dry milk in TBST buffer (5 mmol/l Tris-HCl, pH 7.4, 136 mmol/l NaCl, 0.1% Tween 20) for 1 h at room temperature, the blots were incubated overnight at 41C with a 1:100 dilution of goat anti-Omi/HtrA2 antibody (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). The blots were then washed three times with TBST buffer, incubated for 2 h at room temperature with horseradish peroxidase-linked goat anti-rabbit immunoglobulin G (Santa Cruz Biotechnology Inc., USA) at a dilution of 1:5000, and after further washing, the immunoreactive proteins were visualized by chemiluminescence. (Pierce Biotechnology, Rockford, IL, USA) and quantified by densitometry using Dolphin software (Wealtec CORP, USA).
Statistics
The data were expressed as mean7s.e.m. Statistical analysis was performed using Fisher's least significant difference test or the Kruskall-Wallis test, as appropriate. Po0.05 was considered statistically significant.
Results
Semen quality and inflammatory cytokines in samples of patients with chronic prostatitis
To examine whether there might be a correlation between an inflammatory state owing to an autoimmune response against the prostate gland and the different seminal parameters, we performed semen analyses in the groups of patients under study. The results are presented in Table 1 . No significant differences were found in the pH and volume of the ejaculates of the two groups under study (Table 1) . When prostate and seminal vesicle markers (citric acid and fructose, respectively), were evaluated, citric acid levels appeared to be significantly reduced in group A with clinical symptoms of prostatitis. When we analysed the levels of TNF-a and IL-1b in seminal plasma of these patients, samples from group A showed a significant enhancement of these cytokines in seminal plasma (Table 1) . Sperm motility appeared to be diminished, although not significantly, in samples from groups A and B patients (Table 1) .
Omi/HtrA2 mRNA assay result in prostatitis
With RT-PCR, the expression of Omi/HtrA2 mRNA was detected in human ejaculated spermatozoa (Figure 1a) . GAPDH mRNA was used as an internal control (Figure 1a) . Expression of Omi/HtrA2 mRNA was significantly lower in prostatitis men than in control men (Figure 1b, Po0.01 ).
Omi/HtrA2 protein assay results in prostatitis
The protein expression of Omi/HtrA2 in ejaculated spermatozoa was also confirmed by Western blot (Figure 2a) . Again, the expression of Omi/HtrA2 was significantly lower in control men than in prostatitis men (Po0.01, Figure 2b) , which was consistent to the results from RT-PCR.
Discussion
Chronic prostatitis is a very common disease in the male genitourinary system. However, the relationship between chronic prostatitis and fertility has been controversial for many years. 7,9-11 Some reports have associated chronic prostatitis with abnormalities in semen quality and sperm morphological and motility alterations, mainly of infectious origin or autoimmune lymphoproliferative response to prostate antigens. 4, 7, 12 In contrast, some groups did not find differences in sperm concentration, percentage of motility or morphology among patients with chronic prostatitis, prostatodynia and a control group. 13, 14 One possible explanation for the contradictory findings could be that chronic nonbacterial prostatitis comprises a heterogeneous group of patients. However, the overall explanation is not fully understood. Recently, Motrich et al. 4 have demonstrated that chronic prostatitis patients with cellular autoimmune response to prostate antigens present important alterations in their semen quality parameters, they speculate that an autoimmune response against prostate antigens and the inflammatory process involved may affect male fertility. It has been reported that negative Omi/HtrA2 release from spermatozoa XY Hu et al effects on sperm motion, viability, HOS test and lateralhead displacement are evident after incubation of sperm cells with TNF-a and Iinterferon-g, moreover, the negative effects on sperm motion are evident as soon as 30 min after incubation of sperm cells with TNF-a. 15 TNF and IL-1 are known to cause activation of nuclear factor-kB and result in increased expression of catabolic factors with destruction of cell. Our experiment also demonstrated that chronic prostatitis patients presented significantly elevated levels of TNF-a and IL-1 in seminal plasma and reduced semen quality in chronic prostatitis patients, which would associate with infertility. On the other hand, the expression of proapoptosis factor Omi/ HtrA2, which can be released by TNF-a and IL-1 was upregulated accordingly. It appears to that Omi/HtrA2 might play a pivotal role in the development of chronic prostatitis. Omi/HtrA2 is a nuclear-encoded mitochondrial serine protease serving as a sensor of unfolding stresses in the mitochondria. In the mutant mnd2 mice, loss of the Omi/HtrA2 protease activity leads to mitochondrial disintegration, neuronal degeneration and death. 16 It has been shown that, once in the cytoplasm, Omi/HtrA2 promotes caspase activation and cell apoptosis by binding to the baculovirus inhibitor of apoptosis (IAP) repeat domain of the mammalian caspase inhibitor IAP. 17 Omi/HtrA2 binding displaces IAP from caspases, inhibiting the suppressive effect on caspase activity. 18 There is also evidence that interaction with IAPs is not the only mechanism involved in Omi/HtrA2-induced cell death, as the serine protease activity of Omi/HtrA2, when localized in the cytosol, is sufficient to cause caspase-independent cell death. 19 Omi/HtrA2 expression and release from mitchrondial mainly associated with extracellular apoptosis signals. As IL-1b and TNF-a are members of a family of cytokines involved in a variety of acute and chronic diseases, we hypothesized that Omi/HtrA2 would potentiate the IL-1b and TNF-a response in sperm; as a result, the sperm survival rate would descend. The prostate secretes components that are involved in the total antioxidant capacity (TAC) of the seminal plasma, and the balance between reactive oxygen species (ROS) present in seminal plasma and TAC is important for the survival of sperm. 20 Pasqualotto et al. 13 reported that TAC was significantly lower in patients with chronic non-infectious prostatitis (with or without leucocytospermia) when compared to control individuals. On the other hand, the deleterious effect of Omi/HtrA2 release from spermatozoa XY Hu et al ROS on semen quality has been documented 21 and a diminished prostate secretory function could be associated with enhancement of sperm apoptosis. ROS also has potential capability on inducing Omi/HtrA2 release.
In conclusion, we identify the possible molecular mechanism between inflammatory cytokines (TNF-a, IL-1b) and Omi/HtrA2 in chronic prostatitis. The upregulation of proapoptosis Omi/HtrA2, inducing by inflammatory process, might seriously compromise the quality of sperm, and therefore affect fertility. Thus, Omi/HtrA2 constitutes a pivotal signalling molecule in the apoptosis pathways initiated by the proinflammatory cytokines IL-1 and TNF in chronic prostatitis, and may represent an important therapeutic target.
